These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 17712719

  • 1. Effect of immunosuppressive and other drugs on the cortisol-cortisone shuttle in human kidney and liver.
    Quinkler M, Jussli J, Bähr V, Pfeiffer AF, Lepenies J, Diederich S.
    Horm Metab Res; 2007 Aug; 39(8):555-9. PubMed ID: 17712719
    [Abstract] [Full Text] [Related]

  • 2. Use of 11alpha-deuterium labeled cortisol as a tracer for assessing reduced 11beta-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject.
    Kasuya Y, Yokokawa A, Takashima S, Shibasaki H, Furuta T.
    Steroids; 2005 Feb; 70(2):117-25. PubMed ID: 15631868
    [Abstract] [Full Text] [Related]

  • 3. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action.
    Seckl JR.
    Curr Opin Pharmacol; 2004 Dec; 4(6):597-602. PubMed ID: 15525550
    [Abstract] [Full Text] [Related]

  • 4. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
    Morris DJ, Latif SA, Hardy MP, Brem AS.
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
    [Abstract] [Full Text] [Related]

  • 5. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.
    Draper N, Stewart PM.
    J Endocrinol; 2005 Aug; 186(2):251-71. PubMed ID: 16079253
    [Abstract] [Full Text] [Related]

  • 6. Endogenous selective inhibitors of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin.
    Latif SA, Pardo HA, Hardy MP, Morris DJ.
    Mol Cell Endocrinol; 2005 Nov 24; 243(1-2):43-50. PubMed ID: 16188377
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice.
    Dhanesha N, Joharapurkar A, Shah G, Kshirsagar S, Dhote V, Sharma A, Jain M.
    Clin Exp Pharmacol Physiol; 2012 Jan 24; 39(1):69-77. PubMed ID: 22060140
    [Abstract] [Full Text] [Related]

  • 8. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
    Stanetty C, Czollner L, Koller I, Shah P, Gaware R, Cunha TD, Odermatt A, Jordis U, Kosma P, Classen-Houben D.
    Bioorg Med Chem; 2010 Nov 01; 18(21):7522-41. PubMed ID: 20851614
    [Abstract] [Full Text] [Related]

  • 9. Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases.
    Stegk JP, Ebert B, Martin HJ, Maser E.
    Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):104-8. PubMed ID: 19022342
    [Abstract] [Full Text] [Related]

  • 10. In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acid.
    Diederich S, Quinkler M, Mai K, Schöneshöfer M, Baehr V, Pfeiffer A, Oelkers W, Eigendorff E.
    Horm Metab Res; 2011 Jan 25; 43(1):66-71. PubMed ID: 20925019
    [Abstract] [Full Text] [Related]

  • 11. The metabolism of steroids, toxins and drugs by 11β-hydroxysteroid dehydrogenase 1.
    Zhou HY, Hu GX, Lian QQ, Morris D, Ge RS.
    Toxicology; 2012 Feb 06; 292(1):1-12. PubMed ID: 22154985
    [Abstract] [Full Text] [Related]

  • 12. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
    Livingstone DE, Walker BR.
    J Pharmacol Exp Ther; 2003 Apr 06; 305(1):167-72. PubMed ID: 12649365
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
    Jang C, Obeyesekere VR, Dilley RJ, Krozowski Z, Inder WJ, Alford FP.
    J Clin Endocrinol Metab; 2007 Aug 06; 92(8):3314-20. PubMed ID: 17519316
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.